)
Edge6 Mar 2026
Upvoted: The Story of Reddit
How Reddit built a unique platform around communities and conversation, turning human insight and intent into a distinctive business model.
Corvus Pharmaceuticals
Corvus Pharmaceuticals (CRVS) investor relations material
Corvus Pharmaceuticals Oppenheimer 36th Annual Healthcare Life Sciences Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Oppenheimer 36th Annual Healthcare Life Sciences Conference summary26 Feb, 2026
Pipeline and clinical development
Lead asset soquelitinib is in a phase III trial for peripheral T-cell lymphoma and about to enter phase II for atopic dermatitis, with additional phase II proof-of-concept studies in asthma and hidradenitis suppurativa planned for this year.
Interim analysis for the lymphoma trial is expected by year-end 2026, and the phase II atopic dermatitis trial will provide data in about 18 months.
Soquelitinib is supported by strong intellectual property, with composition of matter protection through 2037.
The company is also developing next-generation ITK inhibitors for broader immune and oncology indications.
Mechanism of action and differentiation
Soquelitinib is a selective, covalent ITK inhibitor, modulating multiple inflammatory pathways upstream, unlike most therapies that target single cytokines.
The drug spares RLK and BTK, supporting a favorable safety profile and limiting off-target effects.
ITK inhibition leads to Th1 skewing and conversion of pro-inflammatory Th17 cells to regulatory T cells, potentially inducing durable remission.
The mechanism allows for treatment of a broad range of Th2 and Th17-driven diseases, including atopic dermatitis, asthma, psoriasis, and fibrotic disorders.
Clinical efficacy and safety data
In phase I trials for atopic dermatitis, soquelitinib showed 75% of patients achieving EASI-75, 25% EASI-90, and 33% IGA 0/1 after eight weeks, with a mean EASI reduction of 72%.
Efficacy was consistent across treatment-naive and previously treated patients, including those resistant to prior systemic therapies.
Durable responses were observed, with continued disease control after treatment cessation and no rebound effect, unlike other therapies.
Safety profile was favorable, with no new safety signals, no significant lab abnormalities, and similar adverse events between active and placebo groups.
Explain soquelitinib's durable response mechanism
Impact of including refractory AD patients in trials
Soquelitinib's strategy for pipeline expansion
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Next Corvus Pharmaceuticals earnings date
Q4 202512 Mar, 2026
Corvus Pharmaceuticals
Next Corvus Pharmaceuticals earnings date
Q4 202512 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Corvus Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on developing immune-oncology therapies for the treatment of cancer and immune-related diseases. The company’s pipeline includes drug candidates that target key immune pathways to enhance the body’s immune response against cancer cells. The company is headquartered in Burlingame, California, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage